What's behind the FDA's controversial strategy for evaluating new COVID boosters

By NPR
| August 18, 2022

The FDA is using a controversial strategy to evaluate the next generation of COVID-19 boosters.

Full story

#1

Recent research on Paxlovid shows there is "solid data on its effectiveness," a co-author of the study told HealthLeaders. ...

A new personal protective equipment manufacturing company is set to open in Cincinnati next year. ...